Adjuvant therapy for rectal cancer
作者： John Zalcberg , Michael Michael , Kian F. Foo
DOI: 10.5555/URI:PII:S1043148902700262
关键词:
摘要: Abstract Surgery is the only curative treatment modality in rectal cancer. However, patients with locally advanced T3 or T4 tumors without nodal involvement, risk of local and systemic recurrence high. Adjuvant (postoperative) therapy aims to reduce risks as well distant decrease cancer-related mortality. Postoperative chemoradiotherapy has been gold standard. adjuvant cancer continuing evolve due greater use surgical techniques such total mesorectal excision neoadjuvant (preoperative) radiotherapy new agents. This review summarizes various types therapies, their current status, morbidity these modalities. Copyright 2002, Elsevier Science (USA). All rights reserved.
seminarscolonrectalsurgery.com参考文章(53)
Jean-François Bosset, Valérie Magnin, Philippe Maingon, Georges Mantion, Edouard P Pelissier, Mariette Mercier, Gaelle Chaillard, Jean-Claude Horiot, Preoperative radiochemotherapy in rectal cancer:: Long-term results of a phase II trial International Journal of Radiation Oncology Biology Physics. ,vol. 46, pp. 323- 327 ,(2000) , 10.1016/S0360-3016(99)00411-3
Survival after postoperative combination treatment of rectal cancer. The New England Journal of Medicine. ,vol. 315, pp. 1294- 1295 ,(1986) , 10.1056/NEJM198611133152014
L Pahlman, Adjuvant radiotherapy for rectal cancer: a systematic overview of 8507 patients from 22 randomised trials. Commentary The Lancet. ,vol. 358, pp. 1291- 1304 ,(2001)
Improved survival with preoperative radiotherapy in resectable rectal cancer. The New England Journal of Medicine. ,vol. 336, pp. 980- 987 ,(1997) , 10.1056/NEJM199704033361402
P G Johnston, E R Fisher, H E Rockette, B Fisher, N Wolmark, J C Drake, B A Chabner, C J Allegra, The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer. Journal of Clinical Oncology. ,vol. 12, pp. 2640- 2647 ,(1994) , 10.1200/JCO.1994.12.12.2640
Rolf Sauer, Rainer Fietkau, Christian Wittekind, Peter Martus, Claus Rödel, Werner Hohenberger, Gerhard Jatzko, Hubert Sabitzer, Johann-Hinrich Karstens, Heinz Becker, Clemens Hess, Rudolf Raab, Adjuvant versus neoadjuvant radiochemotherapy for locally advanced rectal cancer. A progress report of a phase-III randomized trial (protocol CAO/ARO/AIO-94). Strahlentherapie Und Onkologie. ,vol. 177, pp. 173- 181 ,(2001) , 10.1007/PL00002396
Yves Francois, Chantal J. Nemoz, Jacques Baulieux, Jacques Vignal, Jean-Paul Grandjean, Christian Partensky, Jean Christophe Souquet, Patrice Adeleine, Jean-Pierre Gerard, Influence of the Interval Between Preoperative Radiation Therapy and Surgery on Downstaging and on the Rate of Sphincter-Sparing Surgery for Rectal Cancer: The Lyon R90-01 Randomized Trial Journal of Clinical Oncology. ,vol. 17, pp. 2396- 2396 ,(1999) , 10.1200/JCO.1999.17.8.2396
James E. Krook, Charles G. Moertel, Leonard L. Gunderson, Harry S. Wieand, Roger T. Collins, Robert W. Beart, Theodore P. Kubista, Michael A. Poon, William C. Meyers, James A. Mailliard, Donald I. Twito, Roscoe F. Morton, Michael H. Veeder, Thomas E. Witzig, Stephen Cha, Subhash C. Vidyarthi, Effective Surgical Adjuvant Therapy for High-Risk Rectal Carcinoma New England Journal of Medicine. ,vol. 324, pp. 709- 715 ,(1991) , 10.1056/NEJM199103143241101
Olav Dahl, Arild Horn, Inge Morild, Jan F. Halvorsen, Gunnar Odland, Sverre Reinertsen, Arne Reisæter, Helge Kavli, Jan Thunold, Low-dose preoperative radiation postpones recurrences in operable rectal cancer: Results of a randomized multicenter trial in western norway Cancer. ,vol. 66, pp. 2286- 2294 ,(1990) , 10.1002/1097-0142(19901201)66:11<2286::AID-CNCR2820661106>3.0.CO;2-T
Gunilla Jansson Frykholm, Bengt Glimelius, Lars Påhlman, PREOPERATIVE OR POSTOPERATIVE IRRADIATION IN ADENOCARCINOMA OF THE RECTUM: FINAL TREATMENT RESULTS OF A RANDOMIZED TRIAL AND AN EVALUATION OF LATE SECONDARY EFFECTS Diseases of The Colon & Rectum. ,vol. 36, pp. 564- 572 ,(1993) , 10.1007/BF02049863